Study of Anti-CEACAM5 ADC M9140 in Participants With Advanced Solid Tumors (PROCEADE PanTumor)

PHASE1/PHASE2RecruitingINTERVENTIONAL
Enrollment

250

Participants

Timeline

Start Date

January 29, 2025

Primary Completion Date

January 26, 2028

Study Completion Date

January 26, 2028

Conditions
Solid TumorsGastric CancerNon-Small Cell Lung Cancer (NSCLC)Pancreatic CancerPancreatic Ductal Adenocarcinoma (PDAC)
Interventions
DRUG

M9140

All participants will receive 2.8 milligram per kilogram (mg/kg) M9140 intravenously (i.v.) every 3 weeks (q3w) on Day 1 of consecutive 21-day cycles.

Trial Locations (38)

22031

RECRUITING

NEXT Virginia, Fairfax

29605

RECRUITING

Prisma Health Cancer Institute, ITOR, CRU, Greenville

38120

RECRUITING

Baptist Memorial Health Care -Memphis, Memphis

77030

RECRUITING

University of Texas M. D. Anderson Cancer Center - Partner, Houston

90404

RECRUITING

University of California - Los Angeles - 300208353, Santa Monica

95403

RECRUITING

Providence Medical Foundation, Santa Rosa

Unknown

RECRUITING

Flinders Medical Centre, Bedford Park

RECRUITING

Nepean Cancer Care Centre, Kingswood

RECRUITING

Mater Misericordiae Ltd - PARENT, South Brisbane

RECRUITING

Macquarie University Hospital - PARENT, Sydney

RECRUITING

Ordensklinikum Linz Krankenhaus der Elisabethinen Linz - Pneumology, Linz

RECRUITING

LKH - Universitätsklinikum der PMU Salzburg - Innere Med III/Hämatologie und Onkologie, Salzburg

RECRUITING

Institut Bergonié - Service d'Oncologie Médicale, Bordeaux

RECRUITING

Centre Georges François Leclerc - Unité de Phase I, Dijon

RECRUITING

Centre Oscar Lambret - cancerologie generale, Lille

RECRUITING

Hopital Albert Calmette - CHU Lille - CHU Lille - Institut Coeur Poumon, Lille

RECRUITING

Hôpital Européen Georges Pompidou - Hématologie Oncologie, Paris

RECRUITING

Hôpital Saint-Antoine - Oncologie Médicale, Paris

RECRUITING

ICO - Site René Gauducheau - Service d'Oncologie medicale, Saint-Herblain

RECRUITING

Hôpital Foch - Service d'Oncologie Médicale, Suresnes

RECRUITING

Hopital Rangueil - Service d'Oncologie médicale, Toulouse

RECRUITING

National Cancer Center Hospital, Chūōku

RECRUITING

Nara Medical University Hospital - Dept of Oncology, Kashihara-shi

RECRUITING

Cancer Institute Hospital of JFCR, Kōtoku

RECRUITING

Saiseikai Kumamoto Hospital - 300175708, Kumamoto

RECRUITING

Kurume University Hospital, Kurume-shi

RECRUITING

Niigata Cancer Center Hospital - 300176282, Niigata

RECRUITING

Kindai University Hospital, Osakasayama-shi

RECRUITING

NHO Hokkaido Cancer Center - 300175802, Sapporo

RECRUITING

Pusan National University Hospital, Busan

RECRUITING

Kyungpook National University Chilgok Hospital, Daegu

RECRUITING

Chonnam National University Hwasun Hospital, Hwasun-gun

RECRUITING

Seoul National University Bundang Hospital, Seongnam

RECRUITING

Asan Medical Center, Seoul

RECRUITING

Korea University Guro Hospital, Seoul

RECRUITING

Samsung Medical Center, Seoul

RECRUITING

Seoul National University Hospital, Seoul

RECRUITING

Severance Hospital, Yonsei University Health System - Division of Infectious Diseases, Seoul

All Listed Sponsors
collaborator

Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany

INDUSTRY

collaborator

Merck KGaA, Darmstadt, Germany

INDUSTRY

lead

EMD Serono Research & Development Institute, Inc.

INDUSTRY